About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
The University of Kansas Cancer Center
https://www.kucancercenter.org/
2023 Multidisciplinary Oncology Review
2022
Advances in Hematologic Malignancies and Cellular Therapeutics Symposium
2022 Post San Antonio Review
Videos
2021
2021 Virtual KU Hematology and Medical Oncology Review
2021 Post San Antonio Review
2021 KUMC Virtual Multidisciplinary Oncology Review
2020
ASH Review VIRTUAL 2020: Current Updates in Hematologic Diseases
2020 ASCO Highlights
2019
2019 Post San Antonio Breast Cancer Review
ASH 2019 Review: Current Updates in Hematologic Diseases
2019 Lung Cancer and Head & Neck Cancer Symposium
Hematology & Medical Oncology Review 2019
Lung
Hematologic Malignancies
Gastrointestinal
Head and Neck
Genitourinary
Skin
Palliative
General
Event
2018
ASH: Current Updates in Hematologic Diseases
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in mBC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Colleen Bohnenkamp
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Colleen Bohnenkamp
344 views
June 16, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Videos
12:21
Insights from 2023 SABCS
SABCS 2023 Insights: "How to Treat TNBC"
Feat.
P. Sharma
09:24
The University of Kansas Cancer Center
Treatment Sequence in mTNBC
Feat.
P. Sharma
07:47
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose C…
Feat.
C. Bohnenkamp
14:05
The University of Kansas Cancer Center
Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untrea…
Feat.
M. Hoffmann
13:40
SABCS 2021 Conference Coverage on VuMedi
Optimizing Use of HER2 Therapies in MBC
Feat.
P. Sharma
10:44
The University of Kansas Cancer Center
Phase II DREAMM-2: Belantamab Mafodotin in R/R MM
Feat.
A. Abdallah
07:59
The University of Kansas Cancer Center
2021 ASCO Updates From LIMBER-313 on Myelofibrosis: Parsaclisib + Ru…
Feat.
A. Yacoub
08:58
The University of Kansas Cancer Center
ASCO 2021 Update on mTNBC: Considering Outcomes With Romidepsin / Ci…
Feat.
P. Sharma
11:45
The University of Kansas Cancer Center
2021 Updates on MF: Addition of Parsaclisib in Patients With Subopti…
Feat.
A. Yacoub
06:08
The University of Kansas Cancer Center
2020 Update on PARPi/Chemo Option in mTNBC: How Effective Is the Add…
Feat.
P. Sharma
